Filing Flows › Haemonetics (HAE) › Recalls, complaints & regulation
Haemonetics (HAE): recalls
Haemonetics (HAE) beyond its filings: 0 recalls in the last 12 months (2 in five years, 0 Class I).
Latest recalls
- 2022-07-06 · FDA device · TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034
- 2022-07-06 · FDA device · Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping Assay - PlateletMapping ADP & AA (07-014
Haemonetics' latest quarter
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
Questions
Has Haemonetics had any recalls?
2 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.